Bristol Myers Squibb Co. (BMY)
58.32
+0.43
(+0.74%)
USD |
NYSE |
Apr 16, 13:23
Bristol Myers Squibb Cash from Investing (TTM) : -4.132B for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Amgen, Inc. | -1.943B |
| Biogen, Inc. | -1.371B |
| Gilead Sciences, Inc. | -4.793B |
| Janux Therapeutics, Inc. | -300.98M |
| Moderna, Inc. | 1.946B |